Caricamento...
Updates on immunotherapy for colorectal cancer
Despite significant advances in standard of care therapies, the 5-year survival rate for metastatic colorectal cancer (CRC) remains around 12%. Immunotherapy has not provided the stellar advances in colorectal cancer that has been seen in other malignancies. Immunotherapy appears to play a pivotal r...
Salvato in:
| Pubblicato in: | J Gastrointest Oncol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5848033/ https://ncbi.nlm.nih.gov/pubmed/29564182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2018.01.17 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|